We perform an important task: the transfer of basic research results into products, which contribute to the economic and social progress.
Protein Cristallography (XDS)
Our technologies are as varied as the Max Planck Institutes themselves
Themis Bioscience Announces Exclusive Licensing Agreement with Max Planck Innovation to Develop and Commercialize Oncolytic Virotherapies
Themis announced today that it has entered into a license agreement with Max Planck Innovation ...
Do you want to receive our newsletter and press releases?